Found "Vaccines": 76 results
Bhutan’s oldest newspaper shows appreciation on iDSI’s support to evaluate new vaccines in Bhutan
Bhutan’s national and also the oldest newspaper named ‘Kuensel’ from the Kuensel Corporation Limited published a story featuring, our support to the Bhutanese government in evaluating new vaccines through an economic evaluation, in their issue of 28th August 2017 http://www.kuenselonline.com/moh-exp
Feasibility study of the Community Health Initiative for Maternal and Child Health in Myanmar
The Union of Myanmar is the largest country in mainland South-East Asia with a population of 57.5 million. It has a pluralistic mix of public and private healthcare systems. Although the Ministry of Health (MoH) is the main organisation responsible for healthcare provision, 70-80% of health service expenditure is now absorbed by the households. Thi
An early health technology assessment of target product profiles for COVID-19 vaccines: data for supporting R&D for better vaccine and selecting the right vaccine for maximising public health impact
การระบาดของโรคติดเชื้อไวรัสโคโรนา 2019 (COVID-19) ทำให้มีผู้ติดเชื้อและเสียชีวิตทั่วโลก ทางออกที่ยั่งยืนของวิกฤตครั้งนี้ คือ การมี
Health Technology Assessment Development in Bhutan
Bhutan\'s Ministry of Health, especially the Essential Medicine and Technology Division (EMTD), is one of HITAP\'s long-term partners. From 2018 to 2019, HITAP with PATH supported Bhutan to conduct an economic evaluation for the implementation of a national program for rotavirus vaccination. HITAP also provided and continues to find opportunities f
HTA of COVID-19 vaccines in the Philippines
Adapting a dynamic transmission model developed by National University of Singapore to the Philippines context, in order to address policy questions around COVID-19 vaccine choice, target population for booster doses, and the impact of social gatherings on COVID-19 spread.
HTA of COVID-19 vaccines in Thailand
To calibrate the Covid M SEIR model to Thailand and to build capacity to use the model to address policy questions in Thailand. This project will address COVID-19 vaccination policy questions, such as frequency and target population for booster doses, as well as development of web-based applications to communicate the results to policymakers and ot
Chotika Suwanpanich
Chotika Suwanpanich is a researcher at the Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Thailand. She holds a Doctor of Pharmacy degree from Silpakorn University and has knowledge and experience in health economics, economic evaluations, and impact assessments of health interventions.Chotika has worked o
Pritaporn Kingkaew, PhD.
Pritaporn Kingkaew has been a researcher at HITAP since 2007. She graduated from a joint programme between Srinakharinwirot University, Thailand and the University of Nottingham, UK in 2007 with a Bachelor’s degree in Pharmacy. In 2009, she was awarded the HITAP scholarship to pursue a Master’s degree in Health Economics from the University of York
RESEARCH REPORT: GAVI HEALTH SYSTEM STRENGTHENING SUPPORT (HSS) IN MYANMAR
In 2008, the Government of the Union of Myanmar submitted a proposal for Health Systems Strengthening Support (HSS) to Gavi, a global agency that supports children’s access to vaccines, to bolster efforts for a system-wide approach to address shortcomings in maternal and child healthcare. Approved i
WORKSHOP ON VACCINE ECONOMICS AND FOLLOW-UP ON HTA STUDIES
The International Decision Support Initiative (iDSI) lead by Health Intervention Technology Assessment Program (HITAP) has been working closely with the Health Technology Assessment Committee (HTAC) the nodal agency responsible for health technology assessment (HTA) under the Ministry of Health, Ind
10 / Page